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Background: Trans-anal irrigation (TAI) is used widely to treat bowel dysfunction, although evidence for its use in
adult chronic functional constipation remains unclear. Long-term outcome data are lacking, and the effectiveness of
therapy in this patient group is not definitively known.
Methods: Evidence for effectiveness and safety was reviewed and the quality of studies was assessed. Primary
research articles of patients with chronic functional constipation, treated with TAI as outpatients and published in
English in indexed journals were eligible. Searching included major bibliographical databases and search terms:
bowel dysfunction, defecation, constipation and irrigation. Fixed- and random-effect meta-analyses were performed.
Results: Seven eligible uncontrolled studies, including 254 patients, of retrospective or prospective design were
identified. The definition of treatment response varied and was investigator-determined. The fixed-effect pooled response
rate (the proportion of patients with a positive outcome based on investigator-reported response for each study) was
50.4 % (95 % CI: 44.3–56.5 %) but featured substantial heterogeneity (I2 = 67.1 %). A random-effects estimate was similar:
50.9 % (95 % CI: 39.4–62.3 %). Adverse events were inconsistently reported but were commonplace and minor.
Conclusions: The reported success rate of irrigation for functional constipation is about 50 %, comparable to or better
than the response seen in trials of pharmacological therapies. TAI is a safe treatment benefitting some patients with
functional constipation, which is a chronic refractory condition. However findings for TAI vary, possibly due to varying
methodology and context. Well-designed prospective trials are required to improve the current weak evidence base.Background
Overview of the condition
Chronic constipation may be defined as ‘a symptom-based
disorder defined as unsatisfactory defecation characterised
by infrequent stools, difficult stool passage, or both, for at
least three months’ [1]. For the purposes of this review,
‘chronic functional constipation’ refers to any condition
fitting broadly within this definition, with no clear under-
lying cause. This includes obstructed defecation syndrome
(ODS), functional defecation disorder (FDD), chronic idio-
pathic constipation (CIC), and constipation-predominant
irritable bowel syndrome (IBS-C). This reflects the consid-
erable overlap in symptoms between each of these condi-
tions [2], and also the fact that observational studies* Correspondence: Christopher.Emmett@nhs.net
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ondary to a neurological cause (for example, spinal cord
injury, stroke, Parkinson’s disease, Multiple Sclerosis),
opioid-induced constipation or constipation secondary
to any other medical diagnosis.
Chronic constipation is a common condition in the com-
munity: a recent systematic review [3] gave a pooled preva-
lence of 14 %, although it becomes more common in older
people and women. There is a considerable burden of
symptoms and decreased quality of life [1]: one recent
study reporting ‘extremely/very bothersome’ symptoms in
72 % of IBS-C patients, 62 % of CIC patients with abdom-
inal symptoms and 40 % of CIC patients without abdominal
symptoms [2]. The costs of treating constipation are sig-
nificant and appear to be increasing; one American study
reported aggregate national (U.S.) costs of Emergencye is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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in 2011 [4].
Trans-anal irrigation
Trans-anal irrigation therapy (TAI) is in widespread use
throughout the UK as a treatment for bowel dysfunction.
Irrigation involves instilling tap water into the rectum
via the anus, using either a balloon catheter or cone de-
livery system. This is attached via a plastic tube to an ir-
rigation bag holding up to 2 l of water; alternatively a
low-volume system consisting of a hand pump and a
cone may be employed. Low-volume systems deliver ap-
proximately 70 ml per irrigation; high-volume systems
deliver up to 2 l of irrigation, although typically only
0.5–1.5 l is required. Patients vary in the frequency and
volume of irrigation depending on their response to
treatment; typically, irrigation is used 2–3 times per
week. The low-volume system is cheaper, costing ap-
proximately £750 p.a. based on alternate-day use, com-
pared with approximately £1400–1900 for high-volume
irrigation, and may be more acceptable to patients. It is
not known which system is more effective.
Irrigation has been used successfully to treat adults
and children with neurogenic constipation [5–7], and
faecal incontinence [8]. Proposed mechanisms of action
include simple mechanical washout, colonic movement
stimulated by the washout, or a combination of these
[8]. However, evidence for the use of trans-anal irriga-
tion therapy for chronic functional constipation in adults
is not universally acknowledged, and there are questions
about long-term benefit [9].
A review of current evidence for irrigation was under-
taken to define what is known about this treatment as
well as to identify areas where evidence is lacking and
further research is required.
Research question
What is the strength of the evidence for trans-anal irri-
gation therapy for chronic functional constipation, with
reference to effectiveness, safety and methodological
quality of studies?Table 1 Inclusion and exclusion criteria
Inclusion Exclusion
Primary research Audit/letters/com
Patients with Chronic Functional Constipation
(Obstructive defaecation and/or slow transit/IBS-C)
Studies in childre
Full articles published in peer-reviewed journals Studies in neurog
English Language Studies where all
Retrograde irrigation using standard equipment
performed at home
Studies in stoma




Primary research articles that include patients with
chronic functional constipation as defined above, treated
with retrograde trans-anal irrigation at home as outpa-
tients, and published in English in indexed journals were
eligible. The following were not eligible for inclusion: arti-
cles solely studying patients with a known cause for their
constipation (e.g., neurogenic constipation, opioid-induced
constipation, other organic cause); conference abstracts,
audits, letters and commentaries; articles studying ante-
grade irrigation (Table 1). Reviews were not included but
relevant review articles [8, 10] were screened for further
relevant studies, as were citations of retrieved studies. No
protocol was registered, however the review was reported
in accordance with the PRISMA statement (2009) [11].
Search strategy
The following databases were systematically searched
through Ovid Online:
 “All EBM Reviews” (comprising: Cochrane Database
of Systematic Reviews (2005 to March 2015), ACP
Journal Club (1991 to March 2015), Database of
Abstracts of Reviews of Effects (1st Quarter 2015),
Cochrane Central Register of Controlled Trials
(March 2015), Cochrane Methodology Register
(3rd Quarter 2012), Health Technology Assessment
(1st Quarter 2015), NHS Economic Evaluation
Database (1st Quarter 2015));
 Embase (1974–2015 Week 15);
 Ovid MEDLINE(R) (1946–April Week 2 2015).
The following search terms were used (searched in ‘all
fields’): “bowel dysfunction”; “defaecation.”; “defecation”;
“constipation”; “irrigation”. The Boolean Operators “AND”
and “OR” were used to combine these terms appropriately
and refine the search (Table 2). The search was limited to
English language articles and to studies in humans.
Abstracts and citations were screened by one re-
searcher (CDE) and potentially relevant articles werementaries/opinion/review articles
n (<18 years) only
enic constipation only
patients have undergone colorectal surgery (resection or rectopexy, etc.)
patients only
ade irrigation only
Table 2 Search of bibliographic databases
Number Searches Results
1 Constipation.afa 90438




6 1 OR 2 OR 3 OR 4 110886
7 5 AND 6 517
8 Limit 7 to English language 452
9 Limit 8 to Humans 405
10 Remove Duplicates from 9 292
aaf all fields (includes Subject headings and all test fields)
Emmett et al. BMC Gastroenterology  (2015) 15:139 Page 3 of 8retrieved. Articles that fulfilled the inclusion criteria
were included in the review. Reference lists of eligible ar-
ticles were searched to identify potentially relevant arti-
cles missed by the original database search. Another
researcher (HJC) reviewed 10 % of the citations and ab-
stracts, as well as 100 % of the full-text articles, to con-
firm appropriate implementation of the eligibility criteria
and accuracy of data extraction. For practical and re-
source reasons a grey literature search was not per-
formed, as the likelihood of finding appropriate studies
not identified in retrieved citations or reviews was con-
sidered very small.
Data collection
Data were extracted from eligible studies using standardised
data collection forms. Data items included study method-
ology, patient information (including demographic details
and definition of ‘constipation’ used), primary outcome data
(including follow up period), duration of use of treatment,
and adverse events reported. The Cochrane assessment of
bias for non-randomised studies tool (ACROBAT-NRSI)
[12] was used to evaluate methodological quality and
sources of bias for the included studies.
Outcomes
The primary outcome was the proportion of patients
with an investigator-reported positive outcome to trans-
anal irrigation therapy.
Secondary outcomes include response by constipation
type, duration of treatment use and safety of treatment
assessed by adverse event reporting in studies.
Analysis
Both qualitative review of study results and quantitative
analysis was performed. Rates of complications are re-
ported and statistical pooling of proportion estimates
was explored using fixed and random effect models
within StatsDirect © Version 3. Both Q and I2 statisticswere calculated to assess study heterogeneity. An Egger
test was performed to assess risk of publication bias.
Results
Of 292 abstracts and citations reviewed, 19 full-text arti-
cles were retrieved. Of these, six were suitable to be in-
cluded in the review [9, 13–17]. Reference lists of these
articles were reviewed and a further eligible article was
identified [18], giving a total of 7 articles (Fig. 1). All eli-
gible studies reported outcomes using high-volume irriga-
tion only. One further study using low-volume irrigation
was found, not reporting constipation-specific outcomes
and was excluded from the final analysis [19]. Studies
identified were prospective cohort studies, or retrospect-
ive, uncontrolled case series from European nations
(Table 3). In each study the patient case mix included pa-
tients with faecal incontinence, soiling and following colo-
rectal surgery. However the articles reported outcomes
separately for each group, making it possible to evaluate
outcomes for chronic functional constipation. Reported
mean duration of therapy varied from 8 months to
102 months (range 1–216 months across studies).
Studies were small, with an average number of patients
per study of 36 (range 10–79); there was no evidence of
a power calculation being performed for any study.
Outcome of anal irrigation therapy
Patient-reported satisfaction, either subjective or using a
visual-analogue scale, was the outcome most commonly
reported (5 studies) [13, 15–18]. One study used reso-
lution of symptoms as the outcome measure [14], another
used a combination of patient-reported symptom im-
provement and ongoing use of treatment [9]. If a patient
died while still using the treatment this was also consid-
ered successful. One study [13] reported both patient-
reported satisfaction and change in Cleveland constipation
score as markers of treatment success; the patient-
reported satisfaction outcome was included in this analysis
as it enabled meaningful comparison with other studies.
Studies report variable response rates to therapy
(Table 4). The proportion of patients who had a posi-
tive outcome to therapy varied from 30 % [14] to 65 %
[13, 16]. Overall, 254 patients with chronic functional
constipation were included in studies, with 128 having
a positive response to irrigation therapy (Table 4).
A fixed effect analysis of proportions gave a pooled re-
sponse rate of 50.4 % (95 % CI: 44.3–56.5 %). Although
there was no evidence of publication bias (Egger: bias =
0.259, p = 0.91), there was evidence of substantially hetero-
geneity between studies (Q[6] = 18.2, p = 0.0057; I2 =
67.1 %). A random effects estimate was similar, if less pre-
cise: 50.9 % (95 % CI: 39.4–62.3 %), (see Fig. 2).
Four studies reported results for different sub-types of
constipation (Table 5). Sample sizes in all studies were
Table 3 Study characteristics
Study Design and methods Level of
evidencea
Definition of constipation Definition of successful
treatment
Chan [13] Prospective cohort study III Infrequent passage of stool





Christensen [9] Retrospective questionnaire
survey and case note review
III Idiopathic constipation including slow transit,
obstructed defecation and ‘undetermined’
i)→ Ongoing use
ii)→ Resolved symptoms
iii)→ Still using irrigation at
time of death
Koch [14] Prospective cohort study III <2 bowel motions per week, straining or incomplete




Cazemier [15] Retrospective case series
questionnaire survey
III Constipation according to Rome II criteria Patient-reported satisfaction
Gosselink [16] Retrospective case series,
questionnaire survey
III Obstructed defecation based on; straining, incomplete
evacuation, digitation, fullness, <3 motions/ week
Patient-reported satisfaction
Gardiner [18] Case series; not stated if
prospective or retrospective
III Obstructive defecation and slow transit
(?which criteria used)
Patient-reported satisfaction
Crawshaw [17] Retrospective case note
review and questionnaire
survey
III The inability to evacuate the rectum when desired
(includes obstructed defecation and dyssynergic
defecation)
10 mm increase on VAS
(10 % improvement)
aEccles, Mason 2001 How to develop costconscious guidelines [25]
Fig. 1 PRISMA flowchart. Flowchart showing number of abstracts and articles reviewed, numbers excluded, reasons for exclusion, numbers
included in final analysis
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Table 4 Demographics and overall response to treatment










Chan [13] 60 46 8:52 39 (65) 6a 10.7a
Christensen [9] 79 52a 25:62a 27 (34) 21 (1–116)a 8 (1–85)a
Koch [14] 10 55.4 4:7a 3 (30) 3a -
Cazemier [15] 12 46 1:3 6 (50) - 102 (30–216)a
Gosselink [16] 37b 54 5:32 24 (65) 56 (8–154)a d
Gardiner [18] 41 - - 21 (51) - -
Crawshaw [17] 15 54 (41–61)a 13:35a 8 (53) 12ac -
Total 254 - - 128
aWhole cohort
bObstructed Defaecation only
cInferred from study report
dNot stated, but 73 % of patients still using TAI at 30 months
-Data not available
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between sub-groups remain anecdotal. When results
from all four studies where results for different types
of constipation are reported are combined, there was
no consistent pattern of outcome between subtypes.
Methodological weaknesses, inconsistencies in out-
come measures and small sample sizes limit meaning-
ful comparison.
Safety of anal irrigation therapy
The most clinically significant risk associated with irriga-
tion is bowel perforation. Only one study reported this
complication [9] and this occurred in two patients. If re-
liably reported, this represents 2 perforations in approxi-
mately 110,000 irrigations, or less than 0.002 % risk per
irrigation. No studies reported mortality associated with
irrigation. Studies were inconsistent in their reporting of
adverse events and the level of disaggregation betweenFig. 2 Proportion Meta-analysis plot [random effects] Forest plot showing
95 % confidence intervalspathologies treated, thus only a narrative summary is
possible.
Minor and self-limiting adverse events were common-
place in studies but may to some extent have been toler-
ated by patients, with up to 74 % of long term
continuing users reporting some form of related and ex-
pected adverse events in one study [16]. The most
commonly-reported adverse events included abdominal
cramps/discomfort (33–40 %) [9, 15, 16]; anorectal pain
(5–25 %) [9, 16]; anal canal bleeding (1–20 %) [9, 13];
leakage of irrigation fluid (30–75 %) [9, 16]; and expul-
sion of the rectal catheter (39 %) [9]. One study reports
a 43 % incidence in ‘technical problems’ with irrigation
[16]. In one study, 28 % of those discontinuing therapy
gave side effects or technical issues with irrigation as a
reason for discontinuing [9].
Therefore, whilst one or more side effects were experi-
enced by a large proportion of patients undergoing analresponse rates for each study, plus pooled response (diamond) with
Table 5 Risk of bias assessment
Risk of bias by type







Chan [13] Moderate Low Low Low Moderate Moderate Low Moderate
Christensen [9] Moderate Moderate Moderate No
information
Low Serious Low Serious
Koch [14] Moderate Low Low Low Low Moderate Low Moderate
Cazemier [15] Serious Serious Serious Low Low Serious Low Serious










Crawshaw [17] Moderate Serious Serious Low Serious Serious Low Serious
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or irreversible complications was very low.Methodological quality
Generally, the studies were of weak methodology. There
were no randomised controlled studies or case-
controlled studies and most articles were retrospective
questionnaire and case note based case series (Table 3).
Two studies [13, 14] were prospectively designed with
fixed follow up points, but numbers were relatively small
(only 60 and 11 chronic functional constipation patients
respectively). A further study [18] did not state whether
data collection was prospective or retrospective.
Risk-of–bias assessment suggests that five studies were
at serious risk of bias, and the other two were at moder-
ate risk (Table 5). The retrospective questionnaire-based
studies also suffered from non-response to surveys and
missing data. This is likely to lead to bias and the results
must be interpreted in light of this (i.e., were responders
significantly more or less likely to have responded well
to irrigation therapy?). Given the limitations of design
and size, available studies are unable to provide robust
evidence for the treatment effect of trans-anal irrigation.
Patient heterogeneity was also an issue. One study in-
cluded both children and adult patients together [9] and
the proportion of children was not reported. Neither
was it stated whether there was a difference in outcome
between the adults and children. One study [15] in-
cluded three patients with neurological problems in its
constipation cohort, representing 25 % of this study
population. As neurogenic constipation may respond dif-
ferently to irrigation [20], this may have affected the re-
sults. A further study included 5 patients out of 11 with
chronic constipation who had had colorectal surgery
(one resection and four rectopexies) [14]. Another study
[17] also included patients who had undergone pelvic
surgery or rectopexy in the chronic constipation cohort.
It is not known precisely what effect these inclusionshad on response to treatment but these remain a poten-
tial source of confounding.
Discussion
This review brings together the findings of seven pri-
mary research studies which examine outcomes of
trans-anal irrigation therapy in patients with chronic
functional constipation.
Studies retrieved are small and not of robust methodo-
logical quality; only two are prospectively-designed, and
there is the potential for reporting bias in the four stud-
ies that use questionnaires. This finding underlines the
fact that the evidence for use of irrigation in functional
constipation is currently weak.
The aggregate success rate of irrigation therapy is
around 50 % based on these seven studies. Given the
chronic and refractory nature of the symptoms in many
of these patients this may be considered adequate, espe-
cially given the simple and reversible nature of the treat-
ment [8]. By comparison, response rates for drug
treatments in this group of patients has been reported as
20–40 %, though these are prospective RCTs reporting
symptom based primary end-points [21–23]. Addition-
ally, reported response rates in neurogenic constipa-
tion are only slightly higher-around 60 % [5]. Mean
duration of use of treatment was reported between
8 months and 102 months. Inconsistencies in reporting
findings, methodological differences and weak study
design mean that there is insufficient evidence to state
with any confidence exactly what the duration of bene-
fit of treatment should be.
The majority of patients experience some form of ad-
verse event although these are mostly minor, reversible
and self-limiting. This may be a factor in determining the
success of therapy: the need for high levels of patient mo-
tivation, as well as support from specialist nurses, is recog-
nised [8]. The rates of life threatening complications are
very low throughout the studies: Irrigation can be consid-
ered a safe therapy, when used with proper training.
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how best to tailor therapy to patient symptoms. A recent
review based on expert consensus [24] has proposed a
number of regimes to overcome problems with irrigation
and so improve outcomes, but experimental trial evidence
is lacking, especially for functional constipation patients.
In spinal cord injured patients, it has been found that
emptying the rectosigmoid using irrigation stimulates co-
lonic transit [24] however it is not clear whether this is
transferable to patients with slow colonic transit and func-
tional constipation. Scintigraphic studies have suggested
that these patients have a different response to irrigation,
with reduced colonic clearance compared with spinal cord
injured patients [20]. In addition, none of the studies as-
sess outcomes of low-volume anal irrigation systems.
Two previous systematic reviews examining trans-anal
irrigation were found [8, 10]. These reviews, while valu-
able, have several limitations: They focus on irrigation as a
therapy for several conditions including neurogenic con-
stipation, faecal incontinence, idiopathic constipation and
mixed symptoms; also, one review [10] incorporates stud-
ies of inpatient pulsed irrigation which is a very different
therapy from home irrigation described in this review.
The findings of this review are similar to the previous
studies with respect to the weak nature of current evi-
dence and the heterogeneity of the studies included. Sub-
sequent to these reviews further studies have been
identified and this review is the first to address irrigation
therapy in idiopathic constipation only. This is also the
first systematic review on this topic to be conducted in ac-
cordance with the PRISMA statement. Additionally, this is
the first meta-analysis of the effectiveness of irrigation in
chronic functional constipation.
Conclusion
This review suggests that trans-anal irrigation may be an
effective therapy for chronic constipation, and may be
considered in patients who have not responded to medical
management. Irrigation is safe and its effectiveness is at
least comparable with pharmacological therapies. How-
ever, the evidence to guide its use in chronic functional
constipation is weak, and its long-term benefits are un-
clear. There are no reported data on cost-effectiveness of
irrigation: whether treatment provides good value for
money from scarce health service resources. There is a
clear need for well-designed prospective trials to evaluate
the effectiveness, duration, and adverse consequences of
treatment, as well as to assess how best to tailor therapy
to individual patients. Future studies should have defined
outcome measures, for example improvement in validated
quality-of-life questionnaires within a defined time point.
More evidence about the comparative effectiveness and
cost-effectiveness of low-volume and high-volume irriga-
tion systems would also be valuable.Abbreviations
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